• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Co-occurring substance use disorders are common in pregnant women

byNancy LuandAvneesh Bhangu
December 24, 2021
in Obstetrics, Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Approximately 7% of pregnant women were diagnosed with at least one substance use disorder at delivery.

2. Many patients had co-occurring substance use disorders, the most common of which was tobacco and cannabis use disorders.

Evidence Rating Level: 2 (Good)

 In the past decade, research has demonstrated an increase in substance use in pregnancy, including opioid, amphetamine, and cannabis use. Each of these substances are associated with adverse fetal outcomes, including growth restriction and preterm birth. Multiple substance use disorders (SUDs) may exacerbate this issue. Thus, it is important to understand the prevalence of polysubstance abuse amongst pregnant women.

This study was a nationally representative stratified sample from the National Inpatient Sample (NIS) administered by the United States (US) Agency of Healthcare Research and Quality. Participants were included if they were aged 15-44 and had a hospital delivery between 2007 and 2016 (weighted N=38 million). Patients were excluded if they did not have a delivery hospitalization. Information about substance use disorders was collected through the diagnosis codes recorded from NIS.

This study showed that overall, 7.3% of women were diagnosed with at least one SUD, including tobacco, cannabis, opioid, amphetamine, alcohol, sedative, or cocaine. Co-occurring SUDs were also common, the most common combination being tobacco and cannabis. Those who used sedatives had an 83.7% chance of using at least one other substance. This study was limited in its use of diagnosis codes to categorize SUD (which likely underestimated the true prevalence of SUDs). Furthermore, there was limited information to differentiate whether these substances were prescribed and misused versus illicit substance use. Despite these limitations, this study encourages further study on the effect of multiple substances on pregnancy outcomes.

RELATED REPORTS

Early induction of labour reduces shoulder dystocia rates in large for gestational age fetuses

Cannabis use frequency increased following legalization with a decrease in misuse observed

Atosiban does not improve neonatal outcomes in threatened preterm births between 30-34 weeks

Click to read the study in Journal of Addiction Medicine

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alcoholcannabisdrugopioidpregnancypregnantsedativesubstance use disorder
Previous Post

Severe gastrointestinal involvement in children with SARS-CoV-2 infection and multisystem inflammatory syndrome

Next Post

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

RelatedReports

Late gestation antidepressant use linked to postpartum hemorrhage
Obstetrics

Early induction of labour reduces shoulder dystocia rates in large for gestational age fetuses

June 11, 2025
Parental cannabis use increasing, cigarette use decreasing
Psychiatry

Cannabis use frequency increased following legalization with a decrease in misuse observed

May 2, 2025
Increased complications associated with emergent repeat cesarean
Obstetrics

Atosiban does not improve neonatal outcomes in threatened preterm births between 30-34 weeks

May 1, 2025
Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis
Emergency

Acute hallucinogen use demonstrates increased in-hospital mortality

March 12, 2025
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

Compliance-linked incentives increase infant immunizations rates in rural India

No Difference in Antibody or Humoral Responses Among Kidney Transplant Recipients Vaccinated with a 3rd Dose of mRNA or Adenovirus Vector Vaccine

Type 2 diabetes associated with reduction in disability-free life years

2 Minute Medicine Rewind December 27, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.